Cargando…

Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort

BACKGROUND: Despite inhaled medications that decrease exacerbation risk, some COPD patients experience frequent exacerbations. We determined prospective risk factors for exacerbations among subjects in the COPDGene Study taking inhaled medications. METHODS: 2113 COPD subjects were categorized into f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busch, Robert, Han, MeiLan K., Bowler, Russell P., Dransfield, Mark T., Wells, J Michael, Regan, Elizabeth A., Hersh, Craig P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748594/ https://www.ncbi.nlm.nih.gov/pubmed/26861867 http://dx.doi.org/10.1186/s12890-016-0191-7

Ejemplares similares

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study
por: Hayden, Lystra P., et al.
Publicado: (2018)

Lung volumes differentiate the predominance of emphysema versus airway disease phenotype in early COPD: an observational study of the COPDGene cohort
por: Zeng, Siyang, et al.
Publicado: (2023)

CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study
por: Lynch, David A., et al.
Publicado: (2018)

Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants
por: Silverman, Edwin K., et al.
Publicado: (2023)

Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort
por: Baldomero, Arianne K., et al.
Publicado: (2020)

Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies
por: Moll, Matthew, et al.
Publicado: (2020)

Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD
por: Verstraete, Kenneth, et al.
Publicado: (2023)

Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study
por: Hayden, Lystra P., et al.
Publicado: (2015)

Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study
por: Kim, Victor, et al.
Publicado: (2014)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort
por: Martinez, Carlos H, et al.
Publicado: (2014)

Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene
por: Wan, Emily S, et al.
Publicado: (2014)

CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPD
por: Rho, Ji Young, et al.
Publicado: (2018)

Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort
por: Li, Yisha, et al.
Publicado: (2023)

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Erratum: Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study
Publicado: (2023)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Relationship between diffusion capacity and small airway abnormality in COPDGene
por: Criner, Rachel N., et al.
Publicado: (2019)

Validation of a method to assess emphysema severity by spirometry in the COPDGene study
por: Occhipinti, Mariaelena, et al.
Publicado: (2020)

TIARA biannual report #5
por: Aleksan, R., et al.
Publicado: (2013)

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort
por: Cooper, Christopher B, et al.
Publicado: (2020)

Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies
por: Moll, Matthew, et al.
Publicado: (2022)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jardim, Jose R., et al.
Publicado: (2019)

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial
por: Ismaila, Afisi S, et al.
Publicado: (2019)

TIARA biannual report (July 2011)
por: Aleksan, R., et al.
Publicado: (2011)

TIARA biannual report (January 2012)
por: Aleksan, R., et al.
Publicado: (2012)

Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers
por: Gregory, Andrew, et al.
Publicado: (2022)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

TIARA biannual report #4 (February 2013)
por: Aleksan, R., et al.
Publicado: (2013)

The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial
por: Han, MeiLan K., et al.
Publicado: (2020)

Deep learning on graphs for multi-omics classification of COPD
por: Zhuang, Yonghua, et al.
Publicado: (2023)

Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT
por: Dransfield, Mark T., et al.
Publicado: (2021)

Upgrade trigger: Biannual performance update
por: Aaij, Roel, et al.
Publicado: (2017)

Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
por: Tabberer, Maggie, et al.
Publicado: (2020)

Biannual Spawning and Temporal Reproductive Isolation in Acropora Corals
por: Gilmour, James P., et al.
Publicado: (2016)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD
por: Dobler, Claudia C.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tluurkdmstdv0rmqj2jfdk4fsb